| Methods |
Randomised prospective comparative study |
| Participants |
Unclear but likely premenopausal women with submucosal fibroids undergoing hysteroscopic myomectomy |
| Interventions |
‐ Group A: norethisterone acetate 10 mg 2 times per day
‐ Group B: micronised progesterone 200 mg 1 time per day
‐ Group C: dienogest 2 mg 1 time per day
‐ Group D: ulipristal acetate 5 mg 1 time per day
‐ Group E: control group with no treatment |
| Outcomes |
Fluid balance, cervical canal dilatation time, resection and total operation time,
complications, second‐look procedures, conversion to bipolar resectoscopy |
| Notes |
Conference proceeding. Irrelevant clinical outcomes reported in this conference proceeding. This trial included 5 arms (ulipristal acetate, dienogest, micronised progesterone, norethindrone acetate, placebo). Investigators reported on surgical outcomes at hysteroscopic myomectomy, including fluid balance, cervical canal dilatation time, resection and total operation time, complications, second‐look procedures and conversion to bipolar resectoscopy. Total of 7 participants were recruited at time of publication. None of these participants were treated with an SPRM |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
Not stated |
| Allocation concealment (selection bias) |
Unclear risk |
Not stated |
| Blinding of participants and personnel (performance bias)
All outcomes |
Unclear risk |
Not stated |
| Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Not stated |
| Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Not stated |
| Selective reporting (reporting bias) |
Unclear risk |
Not stated |
| Other bias |
Unclear risk |
Data in form of conference proceedings. No published follow‐up data |
